Showing results (31-40 of 46) with videos related to
Sort By:
Pageof 5
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 12, 2013
Therapeutic DNA vaccination using in vivo electroporation followed by standard of care therapy in patients with genotype 1 chronic hepatitis COla Weiland, Gustaf Ahlén, Helmut Diepolder, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2009
Interaction of the hepatitis B core antigen and the innate immune systemByung O Lee, Amy Tucker, Lars Frelin, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 2, 2012
TCR-redirected human T cells inhibit hepatitis C virus replication: hepatotoxic potential is linked to antigen specificity and functional avidityAnna Pasetto, Lars Frelin, Soo Aleman, et al.The Journal of General Virology|May 23, 2001
Humoral and CD4(+) T helper (Th) cell responses to the hepatitis C virus non-structural 3 (NS3) protein: NS3 primes Th1-like responses more effectively as a DNA-based immunogen than as a recombinant proteinUna Lazdina, Catharina Hultgren, Lars Frelin, et al.Hepatology (Baltimore, Md.)|May 29, 2009
Nonstructural 3/4A protease of hepatitis C virus activates epithelial growth factor-induced signal transduction by cleavage of the T-cell protein tyrosine phosphataseErwin Daniel Brenndörfer, Juliane Karthe, Lars Frelin, et al.Journal of Virology|November 14, 2008
A mechanism to explain the selection of the hepatitis e antigen-negative mutant during chronic hepatitis B virus infectionLars Frelin, Therese Wahlström, Amy E Tucker, et al.The Journal of Infectious Diseases|June 19, 2013
A heterologous prime/boost vaccination strategy enhances the immunogenicity of therapeutic vaccines for hepatitis C virusAnne Fournillier, Lars Frelin, Emilie Jacquier, et al.Journal of Pediatric Gastroenterology and Nutrition|August 19, 2017
Lack of Association Between Interleukin 28B Polymorphism and Vertical Transmission of Hepatitis CAfrodite Psaros Einberg, Ann-Sofi Duberg, Olga Filipovich, et al.The Journal of Infectious Diseases|January 30, 2020
Blocking Entry of Hepatitis B and D Viruses to Hepatocytes as a Novel Immunotherapy for Treating Chronic InfectionsPanagiota Maravelia, Lars Frelin, Yi Ni, et al.Gut|August 17, 2022
Novel prime-boost immune-based therapy inhibiting both hepatitis B and D virus infectionsRani Burm, Panagiota Maravelia, Gustaf Ahlen, et al.Pageof 5